Controversies around the treatment of peritoneal metastases of colorectal cancer

doi:10.4251/wjgo.v17.i1.100199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (190)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

116

Sum=125

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=52

Jan 15, 2025 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Jan 15, 2025; 17(1): 100199
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100199

Controversies around the treatment of peritoneal metastases of colorectal cancer

Francisco J Morera-Ocon, Clara Navarro-Campoy, Ticiano Guastella, Francisco Landete-Molina

Francisco J Morera-Ocon, Francisco Landete-Molina, Department of General Surgery, Hospital General de Requena, Requena 46340, Spain

Clara Navarro-Campoy, Department of Gynecology and Obstetrics, Hospital 9 Octubre, Valencia 46015, Spain

Ticiano Guastella, Department of Pathology, Hospital General de Requena, Requena 46340, Spain

Author contributions: Morera-Ocon FJ drafted the manuscript; Morera-Ocon FJ and Navarro-Campoy C translated and completed the manuscript; Guastella T and Landete-Molina F reviewed the manuscript. All authors contributed to the manuscript revision and approved the submitted version.

Conflict-of-interest statement: The authors have nothing to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Francisco J Morera-Ocon, PhD, Surgeon, Surgical Oncologist, Department of General Surgery, Hospital General de Requena, Paraje Casablanca s/n, Requena 46340, Spain. fmoreraocon@gmail.com

Received: August 9, 2024
Revised: October 24, 2024
Accepted: November 7, 2024
Published online: January 15, 2025
Processing time: 124 Days and 23.5 Hours

Core Tip

Core Tip: Local control of peritoneal metastasis in colorectal cancer requires surgical resection to assist the outcome of systemic chemotherapy and target therapy. Despite the negative results of a randomized phase III trial studying the effect of oxaliplatin as a hyperthermic intraperitoneal chemotherapy (HIPEC) agent, HIPEC therapy may work in synergy with complete surgical resection to achieve locoregional control of the disease. Studies focusing on diagnostic tools to achieve better selection of patients who will benefit from comprehensive treatment (surgery, HIPEC, and systemic chemotherapy) are welcome.